Archives - November 23, 2020

	India's COVID-19 caseload rises to 90.95 lakh with 45,209 new cases The number of active cases remained below five lakh for the 12th consecutive day... Nov 23
	Centre rushes high level teams to Himachal Pradesh, Punjab and Uttar Pradesh to support the States in COVID response and management These States have been either reporting a rise in the number of active cases i.e. those who are hospitalized or are in home isolation ... Nov 23
	Rajasthan imposes night curfew in eight worst affected district HQs due to spike in Covid cases The district headquarters where curfew has been imposed include Jaipur, Jodhpur, Kota, Bikaner, Udaipur, Ajmer, Alwar and Bhilwara. ... Nov 23
	Over 100 deaths reported in Delhi due to coronavirus for third consecutive day With 121 deaths on Sunday, the toll in the city now stands at 8,391... Nov 23
	Dr. Harsh Vardhan addresses Boston Centre for Excellence in Health and Human Development. Dr. Harsh Vardhan, Union Minister for Health and Family Welfare digitally addressed the Boston Center of Excellence for Health and Human Development here today through ... Nov 23
	South Korea reports 271 new COVID-19 cases as tighter curbs to take effect. South Korea reported another daily rise of more than 200 new coronavirus cases on Monday, a day before tighter social distancing rules to blunt the ... Nov 23
	Strides receives USFDA approval for Prednisone Tablets ... Nov 23
	Country's Covid-19 recovery rate improves to 93.68% With the recovery of more than 85 lakh people so far, the national recovery rate has improved to 93.68 percent.... Nov 23
	Jupiter Hospital conducts India’s first pediatric living donor small intestinal transplant Jupiter Hospital, Pune is the only center in Western India performing small intestinal transplants... Nov 23
	IATA addresses COVID-19 vaccine transportation challenges with new guidance Vaccine needs to be shipped and stored in temperature-controlled environment... Nov 23
	Regeneron's REGEN-COV2 is first antibody cocktail for COVID-19 to receive US FDA emergency use authorization The clinical evidence from Regeneron's outpatient trial suggests that monoclonal antibodies such as REGEN-COV2 have the greatest benefit when given early after diagnosis ... Nov 23
	AbCellera-discovered antibody granted interim authorization by health Canada as a treatment for COVID-19 Bamlanivimab received emergency use authorization (EUA) from the U.S. Food and Drug Administration on November 9, 2020... Nov 23
	Cumulative COVID samples testing figure reaches nearly 13.26 crore mark Nearly 8.50 lakh COVID samples were tested in the country in the last 24 hours. With this, the cumulative testing figure has reached nearly ... Nov 23
	BioShin enrolls first patient into an Asia-Pacific regional multi-center phase III clinical trial of rimegepant (BHV-3000) for the acute treatment of migraine BHV3000-310 is a double-blind, randomized trial evaluating the safety and efficacy of rimegepant in the acute treatment of migraine.... Nov 23
	RedHill announces DSMB unanimous recommendation to continue COVID-19 opaganib phase 2/3 study The independent, pre-programmed DSMB unanimously recommends the continuation of the global Phase 2/3 study of orally administered opaganib in severe COVID-19 pneumonia... Nov 23
	Gujarat: Ahmedabad city records eight Covid deaths during last 24 hrs In Gujarat, Ahmedabad city had witnessed 8 Covid deaths during the last 24 hours, which is highest during the last five months.... Nov 23
	Covid recovery rate improves to 96.46% in Tripura In Tripura, the Covid recovery rate has further improved to 96.46 percent as 31,246 people have been cured so far.... Nov 23
	Telangana reports 602 fresh COVID cases during past 24 hrs Telangana reported 602 fresh COVID cases during the past 24 hours. With this, the total COVID cases reported in the state has gone up to ... Nov 23
	GSK starts phase 3 study of RSV maternal candidate vaccine Currently no vaccine is available for respiratory syncytial virus... Nov 23
	PFIZER DOSES FIRST PARTICIPANT IN PHASE 3 STUDY EVALUATING ANTI-TFPI INVESTIGATIONAL THERAPY An anti-tissue factor pathway inhibitor being evaluated for the treatment of people with severe hemophilia A or B, with or without inhibitors.... Nov 23
	European Commission approves MenQuadfi, the latest innovation in meningococcal vaccination The EC has approved MenQuadfi for active immunization against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W and Y.... Nov 23
	AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19 Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vaccine was highly effective in ... Nov 23
	Recently published data on Favipiravir as treatment for mild to moderate COVID-19 demonstrates significant improvement in time to clinical cure The oral antiviral medication Favipiravir, which prevents the replication phase of the virus life-cycle, leads to significant improvement in clinical cure in patients with ... Nov 23
	Merck Submits Applications for Licensure of V114, the Company’s Investigational 15-valent Pneumococcal Conjugate Vaccine ... Nov 23
	Acquisition adds to Merck’s suite of clinical programs in response to SARS-CoV-2/COVID-19 Meaningful new therapeutic options are desperately needed for possibly millions of people around the world who will develop severe or critical COVID-19 disease... Nov 23
25 Stories found!